Beetham Thomas W.
SEC insider (Form 3/4/5 filer). CIK 0001741382. Chief Operating Officer at Viridian Therapeutics, Inc.\DE (VRDN). 8 reported Form 4/5 transactions since Sep 2024; latest on Mar 3, 2026. Located in WALTHAM, MA.
Companies Beetham Thomas W. has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Officer, Chief Operating Officer
Beetham Thomas W.
CIK: 0001741382
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viridian Therapeutics, Inc.\DE
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect3K shares at avg. $30.19$92K - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect9.4K shares- - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect3.1K shares at avg. $29.32$92K - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
35.3K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
176.6K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
37.6K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
225.8K shares- - Sep 27, 2024VRDN
Viridian Therapeutics, Inc.\DE
PurchaseDirect5K shares at avg. $23.41$117K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 3,048 | $30.19 | $92,019 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Exercise | 9,409 | - | $0 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 3,138 | $29.32 | $92,006 | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 35,300 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 176,550 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 37,636 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 225,814 | - | - | Direct |
| Sep 27, 2024 | VRDN Viridian Therapeutics, Inc.\DE | Purchase | 5,000 | $23.41 | $117,050 | Direct |
1-8 of 8 transactions